Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03545061
Other study ID # 2018-4449
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 6, 2018
Est. completion date July 2025

Study information

Verified date October 2020
Source Radboud University
Contact Ayla Turan, MSc
Phone +31(0)611368110
Email ayla.turan@radboudumc.nl
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

A Prospective Study: Longterm Follow Up until S2 (2nd surveillance) at 18 months after EMR for Large Flat/Sessile Colonic Polyps.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date July 2025
Est. primary completion date July 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Flat or sessile polyp morphology (Paris classification 0-IIa/b/c, Is)

- Polyp size >20 mm

- Therapy: EMR

- Age > 18 years old

- Written informed consent

Exclusion Criteria:

- Participation in a competing study, such as the "CLIPPER trial" (registration number: NL62949.091.17).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands Radboudumc Nijmegen Gelderland

Sponsors (1)

Lead Sponsor Collaborator
Radboud University

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Complications Delayed bleeding, perforation and postpolypectomy syndrome 30 days post EMR
Primary Recurrence Pathological and endoscopical re-appearance of adenoma 6 months (S1) and 18 months (S2) after EMR